{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:42:51Z","timestamp":1792874571489,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/SBSRF\/21\/31013"],"award-info":[{"award-number":["FS\/SBSRF\/21\/31013"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.atherosclerosis.2023.117237","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T01:22:06Z","timestamp":1691716926000},"page":"117237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk"],"prefix":"10.1016","volume":"394","author":[{"given":"Felix","family":"Westcott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Dearlove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2648-6526","authenticated-orcid":false,"given":"Leanne","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9733","key":"10.1016\/j.atherosclerosis.2023.117237_bib1","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Emerging Risk Factors","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2023.117237_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","article-title":"Unraveling the regulation of hepatic metabolism by insulin","volume":"28","author":"Titchenell","year":"2017","journal-title":"Trends Endocrinol. Metabol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117237_bib3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4254\/wjh.v7.i6.846","article-title":"Non-alcoholic fatty liver disease: the diagnosis and management","volume":"7","author":"Abd El-Kader","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2023.117237_bib4","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117237_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117237_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2337\/dc07-1463","article-title":"Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects","volume":"31","author":"Kotronen","year":"2008","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.117237_bib7","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/hep.32072","article-title":"Nonalcoholic fatty liver disease and cardiac remodeling risk: pathophysiological mechanisms and clinical implications","volume":"74","author":"Zhou","year":"2021","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117237_bib8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/liv.15556","article-title":"Fatty liver disease, heart rate and cardiac remodelling: evidence from the UK Biobank","volume":"43","author":"Jamialahmadi","year":"2023","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117237_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12020-019-02070-0","article-title":"Association between nonalcoholic fatty liver disease and cardiac function and structure-a meta-analysis","volume":"66","author":"Borges-Canha","year":"2019","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117237_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MOL.0b013e3283462e16","article-title":"Hepatic fatty acid partitioning","volume":"22","author":"Hodson","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2023.117237_bib11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41574-019-0256-9","article-title":"The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state","volume":"15","author":"Hodson","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.117237_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molmet.2015.03.004","article-title":"De novo lipogenesis in metabolic homeostasis: more friend than foe?","volume":"4","author":"Solinas","year":"2015","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.atherosclerosis.2023.117237_bib13","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117237_bib14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/diabetes.48.2.292","article-title":"Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting","volume":"48","author":"Ekberg","year":"1999","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117237_bib15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Defronzo","year":"2009","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2023.117237_bib16","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","article-title":"Mechanism by which metformin reduces glucose production in type 2 diabetes","volume":"49","author":"Hundal","year":"2000","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117237_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI115997","article-title":"Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study","volume":"90","author":"Magnusson","year":"1992","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117237_bib18","doi-asserted-by":"crossref","first-page":"E413","DOI":"10.1152\/ajpendo.2001.281.3.E413","article-title":"Methods for measuring glycogen cycling","volume":"281","author":"Landau","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117237_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3945\/an.112.002089","article-title":"Regulation of hepatic glucose uptake and storage in vivo","volume":"3","author":"Moore","year":"2012","journal-title":"Adv. Nutr."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117237_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metabol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117237_bib21","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1172\/JCI136756","article-title":"Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117237_bib22","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117237_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cmet.2007.03.004","article-title":"Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver","volume":"5","author":"Burgess","year":"2007","journal-title":"Cell Metabol."},{"issue":"29","key":"10.1016\/j.atherosclerosis.2023.117237_bib24","doi-asserted-by":"crossref","first-page":"12121","DOI":"10.1073\/pnas.0812547106","article-title":"Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes","volume":"106","author":"Samuel","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117237_bib25","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117237_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41574-023-00817-4","article-title":"Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases","volume":"19","author":"Haedersdal","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.117237_bib27","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1210\/er.2018-00251","article-title":"The liver-alpha-cell Axis and type 2 diabetes","volume":"40","author":"Wewer Albrechtsen","year":"2019","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2023.117237_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.metabol.2014.04.003","article-title":"De novo lipogenesis in health and disease","volume":"63","author":"Ameer","year":"2014","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117237_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MCO.0000000000000914","article-title":"Nutritional regulation of hepatic de novo lipogenesis in humans","volume":"26","author":"Cross","year":"2023","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117237_bib30","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0021-9258(19)45544-0","article-title":"Metabolism of free fatty acids in isolated liver cells. Factors affecting the partition between esterification and oxidation","volume":"247","author":"Ontko","year":"1972","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2023.117237_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-4939-8769-6_6","article-title":"Measuring human lipid metabolism using deuterium labeling: in vivo and in vitro protocols","volume":"1862","author":"Pinnick","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117237_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100339","article-title":"Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate","volume":"64","author":"Dandan","year":"2023","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.117237_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127368","article-title":"Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with proxies of liver fat accumulation in the EPIC-potsdam study","volume":"10","author":"Jacobs","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117237_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3945\/ajcn.114.092601","article-title":"Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study","volume":"101","author":"Ma","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117237_bib35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3945\/ajcn.111.012054","article-title":"Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study","volume":"94","author":"Wu","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117237_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3945\/ajcn.113.061218","article-title":"Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese","volume":"98","author":"Zong","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117237_bib37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/ajcn\/nqy304","article-title":"Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers","volume":"109","author":"Rosqvist","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2023.117237_bib38","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0022-2275(20)35348-7","article-title":"Quantification of menstrual and diurnal periodicities in rates of cholesterol and fat synthesis in humans","volume":"34","author":"Faix","year":"1993","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117237_bib39","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/oby.20781","article-title":"Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins","volume":"22","author":"Matikainen","year":"2014","journal-title":"Obesity"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117237_bib40","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1172\/JCI6572","article-title":"Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance","volume":"104","author":"Parks","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2023.117237_bib41","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2337\/db16-0236","article-title":"Fasting plasma insulin concentrations are associated with changes in hepatic fatty acid synthesis and partitioning prior to changes in liver fat content in healthy adults","volume":"65","author":"Pramfalk","year":"2016","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117237_bib42","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1172\/JCI118342","article-title":"Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection","volume":"96","author":"Schwarz","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117237_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ajcn\/81.1.35","article-title":"Temporal pattern of de novo lipogenesis in the postprandial state in healthy men","volume":"81","author":"Timlin","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117237_bib44","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1194\/jlr.M600200-JLR200","article-title":"Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans","volume":"47","author":"Vedala","year":"2006","journal-title":"J. Lipid Res."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117237_bib45","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.2337\/db12-0206","article-title":"Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly","volume":"61","author":"Flannery","year":"2012","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117237_bib46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/ajcn\/73.2.253","article-title":"Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men","volume":"73","author":"Marques-Lopes","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.117237_bib47","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117237_bib48","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117237_bib49","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.atherosclerosis.2023.117237_bib50","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1042\/CS20171208","article-title":"Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets","volume":"131","author":"Umpleby","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117237_bib51","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1136\/gutjnl-2012-302789","article-title":"Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease","volume":"62","author":"Croci","year":"2013","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2023.117237_bib52","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1478-3231.2009.02076.x","article-title":"Liver fat and lipid oxidation in humans","volume":"29","author":"Kotronen","year":"2009","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117237_bib53","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2016.06.005","article-title":"Assessment of hepatic mitochondrial oxidation and pyruvate cycling in NAFLD by (13)C magnetic resonance spectroscopy","volume":"24","author":"Petersen","year":"2016","journal-title":"Cell Metabol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117237_bib54","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metabol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117237_bib55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-2275(20)32407-X","article-title":"Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects","volume":"41","author":"Hudgins","year":"2000","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117237_bib56","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1042\/bj2550929","article-title":"Secretion and storage of newly synthesized hepatic triacylglycerol fatty acids in vivo in different nutritional states and in diabetes","volume":"255","author":"Duerden","year":"1988","journal-title":"Biochem. J."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2023.117237_bib57","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002258","article-title":"Menopausal status and abdominal obesity are significant determinants of hepatic lipid metabolism in women","volume":"4","author":"Hodson","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117237_bib58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00041433-199806000-00003","article-title":"Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies","volume":"9","author":"Millar","year":"1998","journal-title":"Curr. Opin. Lipidol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2023.117237_bib59","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2337\/diabetes.47.5.779","article-title":"Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects","volume":"47","author":"Malmstrom","year":"1998","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117237_bib60","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2023.117237_bib61","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/ejcn.2017.145","article-title":"Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study","volume":"71","author":"Hodson","year":"2017","journal-title":"Eur. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117237_bib62","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117237_bib63","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1007\/s00125-007-0790-1","article-title":"Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance","volume":"50","author":"Adiels","year":"2007","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2023.117237_bib64","first-page":"E321","article-title":"Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification","volume":"274","author":"Diraison","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117237_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2337\/db10-0867","article-title":"Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?","volume":"60","author":"McQuaid","year":"2011","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117237_bib66","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3109\/00365518509155279","article-title":"Clearance of triglycerides from the circulation and its relationship to serum lipoproteins: influence of age and sex","volume":"45","author":"Tollin","year":"1985","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2023.117237_bib67","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.1152\/ajpendo.00411.2002","article-title":"VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity","volume":"284","author":"Mittendorfer","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117237_bib68","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12944-017-0625-0","article-title":"Hypertriglyceridemia and atherosclerosis","volume":"16","author":"Peng","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117237_bib69","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.ATV.12.1.6","article-title":"Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants","volume":"12","author":"Nordestgaard","year":"1992","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2023.117237_bib70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1749-6632.1985.tb11860.x","article-title":"Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia","volume":"454","author":"Mahley","year":"1985","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"9943","key":"10.1016\/j.atherosclerosis.2023.117237_bib71","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117237_bib72","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1515\/CCLM.2003.120","article-title":"Identification of lipoproteins of intestinal origin in human atherosclerotic plaque","volume":"41","author":"Pal","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2023.117237_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012881","article-title":"Serial plasma phospholipid fatty acids in the de novo lipogenesis pathway and total mortality, cause-specific mortality, and cardiovascular diseases in the cardiovascular health study","volume":"8","author":"Lai","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2023.117237_bib74","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","article-title":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity","volume":"100","author":"Listenberger","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2023.117237_bib75","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1194\/jlr.M050237","article-title":"Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells","volume":"55","author":"Leamy","year":"2014","journal-title":"J. Lipid Res."},{"issue":"19","key":"10.1016\/j.atherosclerosis.2023.117237_bib76","doi-asserted-by":"crossref","first-page":"11143","DOI":"10.1016\/S0021-9258(19)38569-2","article-title":"Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals","volume":"265","author":"Field","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2023.117237_bib77","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.plipres.2014.02.002","article-title":"Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes","volume":"54","author":"Sahini","year":"2014","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2023.117237_bib78","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00001648-200001000-00017","article-title":"Simpson's paradox: an example from hospital epidemiology","volume":"11","author":"Reintjes","year":"2000","journal-title":"Epidemiology"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2023.117237_bib79","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1172\/JCI118645","article-title":"Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet","volume":"97","author":"Hudgins","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2023.117237_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135329","article-title":"Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes","volume":"10","author":"Mantovani","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2023.117237_bib81","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2023.117237_bib82","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1806747","article-title":"Mendelian randomization study of ACLY and cardiovascular disease","volume":"380","author":"Ference","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023051547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023051547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T15:57:12Z","timestamp":1723737432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023051547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":82,"alternative-id":["S0021915023051547"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117237","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117237"}}